146 related articles for article (PubMed ID: 11088052)
21. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
Kasahara A; Hayashi N; Fusamoto H; Kawada Y; Imai Y; Yamamoto H; Hayashi E; Ogihara T; Kamada T
Dig Dis Sci; 1993 Dec; 38(12):2170-6. PubMed ID: 7505217
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
Kang SH; Kim DY; Jeon SM; Ahn SH; Park JY; Kim SU; Kim JK; Lee KS; Chon CY; Han KH
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):849-56. PubMed ID: 22495400
[TBL] [Abstract][Full Text] [Related]
23. Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).
Matsueda K; Yamamoto H; Yoshida Y; Notohara K
J Gastroenterol; 2006 Oct; 41(10):1011-9. PubMed ID: 17096071
[TBL] [Abstract][Full Text] [Related]
24. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of mutant erythropoietin in hepatocellular carcinoma.
Funakoshi A; Muta H; Baba T; Shimizu S
Biochem Biophys Res Commun; 1993 Sep; 195(2):717-22. PubMed ID: 8396923
[TBL] [Abstract][Full Text] [Related]
26. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM
Scand J Gastroenterol; 2018 Jun; 53(6):734-740. PubMed ID: 29667463
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
Gentile I; Buonomo AR; Scotto R; Zappulo E; Carriero C; Piccirillo M; Izzo F; Rizzo M; Cerasuolo D; Borgia G; Cavalcanti E
In Vivo; 2017; 31(4):695-700. PubMed ID: 28652441
[TBL] [Abstract][Full Text] [Related]
28. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
29. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.
Park MS; Lee KW; Kim H; Choi YR; Hong G; Yi NJ; Suh KS
Transplant Proc; 2017 Jun; 49(5):1109-1113. PubMed ID: 28583537
[TBL] [Abstract][Full Text] [Related]
31. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.
Baek YH; Lee JH; Jang JS; Lee SW; Han JY; Jeong JS; Choi JC; Kim HY; Han SY
Hepatogastroenterology; 2009; 56(91-92):763-7. PubMed ID: 19621698
[TBL] [Abstract][Full Text] [Related]
33. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia.
Miskad UA; Yano Y; Nakaji M; Kishi S; Itoh H; Kim SR; Ku Y; Kuroda Y; Hayashi Y
Pathol Int; 2001 Dec; 51(12):916-22. PubMed ID: 11844063
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
35. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.
Itokawa N; Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Kondo C; Iwakiri K
Int J Clin Oncol; 2016 Aug; 21(4):676-683. PubMed ID: 26701173
[TBL] [Abstract][Full Text] [Related]
36. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
[TBL] [Abstract][Full Text] [Related]
37. Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation.
Gao J; Song P
Drug Discov Ther; 2017; 11(3):168-169. PubMed ID: 28757516
[TBL] [Abstract][Full Text] [Related]
38. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352
[TBL] [Abstract][Full Text] [Related]
39. [A case of bone metastases from hepatocellular carcinoma presenting with erythrocytosis after hepatectomy].
Koida S; Kimura T; Matsuda Y; Inoue M; Shimizu Y
Gan To Kagaku Ryoho; 2014 Feb; 41(2):237-9. PubMed ID: 24743205
[TBL] [Abstract][Full Text] [Related]
40. [Erythropoietin in hepatocellular carcinoma].
Malaguarnera M; Bentivegna P; Di Fazio I; Laurino A; Romano M; Trovato BA
Bull Cancer; 1996 Dec; 83(12):977-80. PubMed ID: 9116377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
